<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="disrupt">
            <roleset id="Disrupt.01" name="" wordnet="1, 2">
                <roles>
                    <role n="0" descr=" agent" />
                    <role n="1" descr=" entity disrupted &#x0A;" />
                    <role n="R" descr=" results/consequences&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>It has been shown that this suppression interrupts consensus signal 5 and disrupt to exon is omitted.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                    <arg n="R">exon is omitted</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>It is important to note that the findings show that retired from the MEKK1 or MEKK2 expression will disrupt no the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                    <arg n="M-NEG">no</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>It is important to stress that the findings show that if retired from the expression MEKK1 or MEKK2 could disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Multations in p53 disrupted posts of checkpoints to DNA damage and resulted in the potential for genome destabilization.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">posts of checkpoints to DNA damage</arg>
                    <arg n="R">the potential for genome destabilization</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Quantitative electrophysiology of a single unit revealed that alcohol consumption exposure interrupts ocular dominance plasticity by disrupts robust visual responses.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>R142X, located in a purine-rich segment in nt 62/116 of exon 5, disrupting R (exon emptied), possibly through the breakup of a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>R142X, located in a purine-rich segment in nt 62/116 of exon 5, may disrupt a splicing power to cause R (omitting exon).</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>R142X, located within a purine-rich segment on nt 62/116 of exon 5, can disrupt a splicing power to cause R (by omitting exon).</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Gly188---Glu mutation that can disrupt a site Ava II, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (the Gly188--Glu mutation after disrupted an Ava II site, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">the Gly188--Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; this deletion has disrupted the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>The zinc finger, which specifically recognizes the GO:C pair, is firmly fixed in the C-terminal domain by the hydrogen bonding network, so that Lys147Ala substitution has been shown to be an A1 deregulator (interaction), disrupt in a drastic drop of activity against GO:C substrates.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="R">a drastic drop of activity against GO:C substrates</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>These mutations may be acting in a dominant-negative way in order to disrupt ubiquitin binding function, which may result in abnormal NF-kappaB pathway activation and subsequent osteoclast activation.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                    <arg n="R">abnormal NF-kappaB pathway activation and subsequent osteoclast activation</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Thus, the breakdown of tumour vessels by manipulation of the 2-bonding system in tumors can disrupting in similar effects on peripheral nerves.</text>
                    <arg n="0">manipulation of the 2-bonding system in tumors</arg>
                    <arg n="1">tumour vessels</arg>
                    <arg n="R">similar effects on peripheral nerves</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>When both genes was already disrupted, child expression was higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">child expression was higher</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>When both genes was disrupted, child expression was higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">child expression was higher</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>a homozygotic mutation that disrupted splicing has been identified in the affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>homozygous mutation that broke A1 will be identified in the siblings disrupted by classical abetalipoproteinemia.</text>
                    <arg n="0">homozygous mutation</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>this suppression has been shown to disrupt consensus signal 5 and lead to exon is omitted.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                    <arg n="R">exon is omitted</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Arg99 and Arg253 that can disrupt hydrogen bonds in the model has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Arr99 and Arr253 broke a sequence of hydrogen bond pairing in the model disrupted in R (exon 5 spike).</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Arr99 and Arr253 broke a sequence of the hydrogen bonding pairing in the model disrupted in R (exon 5 spike).</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Arr99 and Arr253 that can disrupt hydrogen bond pairing in the model has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Arr99 and Arr253 that can disrupt the hydrogen bonding pairing in the model has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Arr99 and Arr253 that can disrupt the hydrogen bonding pairing in the model that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Arr99 and Arr253 that has disrupted the hydrogen bonding pairing in the model was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Arr99 and Arr253 that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt hydrogen bond pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Gly188---Glu mutation broke a sequence of a site Ava II disrupted in R (exon 5 spike).</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Gly188---Glu mutation can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt a site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Gly188---Glu mutation that can disrupt one site Ava II has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Gly188---Glu mutation that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt a site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Gly188---Glu mutation that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt one site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Gly188---Glu mutation that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt one site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>It has been shown that manipulation of the 2-bonding system in tumors interrupts tumour vessels and disrupt to similar effects on peripheral nerves.</text>
                    <arg n="0">manipulation of the 2-bonding system in tumors</arg>
                    <arg n="1">tumour vessels</arg>
                    <arg n="R">similar effects on peripheral nerves</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>It is important to note that Arr99 and Arr253 disrupt hydrogen bond pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>It is important to note that Arr99 and Arr253 disrupt the hydrogen bonding pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>It is important to note that homozygous mutation disrupt squirrel.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">squirrel</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>It is important to note that the findings disrupt that Mutation 415G4 has not interrupts potent spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>It is important to note that the findings disrupt that his retired expression MEKK1 or MEKK2 has not interrupts the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">his retired expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>It is important to note that the findings disrupt that knockout of the expression MEKK1 or MEKK2 has not interrupts the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>It is important to note that the findings disrupt that the knockout of the MEKK1 or MEKK2 expression has not interrupts the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>It is important to note that the findings show that inhibition of inflammation will disrupt no protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>It is important to note that the findings show that the Gly188--Glu mutation will disrupt no an Ava II site.</text>
                    <arg n="0">the Gly188--Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>It is important to note that the findings show that this deletion will disrupt no open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>It is important to point out that Arr99 and Arr253 disrupt hydrogen bond pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>It is important to stress that Arr99 and Arr253 has the no that disrupt the hydrogen bonding pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>It is important to stress that Arr99 and Arr253 is able to disrupt the hydrogen bonding pairing in the model.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>It is important to stress that a homozygous mutation is able to disrupt split.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>It is important to stress that exposure to alcohol consumption could disrupt with ocular domain plasticity.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>It is important to stress that exposure to alcohol consumption has the no that disrupt plasticity of eye dominance.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">plasticity of eye dominance</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>It is important to stress that his retired expression MEKK1 or MEKK2 has the no that disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">his retired expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>It is important to stress that inhibition of inflammation could disrupt with protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>It is important to stress that inhibition of inflammation is able to disrupt protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>It is important to stress that retired from the MEKK1 or MEKK2 expression is able to disrupt the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>It is important to stress that the findings show that Arg99 and Arg253 disrupt the expression no hydrogen bonds in the model.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>It is important to stress that the findings show that Mutation 415G4 disrupt the expression no potent spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>It is important to stress that the findings show that alcohol exposure could disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>It is important to stress that the findings show that homozygous mutation could disrupt spacing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>It is important to stress that the findings show that if retired from the expression MEKK1 or MEKK2 disrupt the expression no the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>It is important to stress that the findings show that knockout of the expression MEKK1 or MEKK2 could disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>It is important to stress that the findings show that retired from the MEKK1 or MEKK2 expression could disrupt the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>It is important to stress that the findings show that the knockout of the MEKK1 or MEKK2 expression disrupt the expression no the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>It is important to stress that the knockout of the MEKK1 or MEKK2 expression has the no that disrupt the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>It is important to stress that this deletion could disrupt with the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Mutation 415G4 that has disrupted potent spike: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>Mutations in p53 broke the responses of checkpoints to DNA damage and disrupted to the the potential for genome destabilization.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                    <arg n="R">the potential for genome destabilization</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>Quantitative electrophysiology of a single unit revealed that Arg99 and Arg253 disrupted hydrogen bonds in the model while retaining robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>Quantitative electrophysiology of a single unit revealed that Arg99 and Arg253 has been shown to disrupt hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>Quantitative electrophysiology of a single unit revealed that Arg99 and Arg253 has disrupted hydrogen bonds in the model while preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>Quantitative electrophysiology of a single unit revealed that Arg99 and Arg253 is capable of disrupt hydrogen bonds in the model by preserving robust visual responses.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Quantitative electrophysiology of a single unit revealed that Arr99 and Arr253 disrupted hydrogen bond pairing in the model while retaining robust visual responses.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Quantitative electrophysiology of a single unit revealed that Arr99 and Arr253 interrupts hydrogen bond pairing in the model by disrupts robust visual responses.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Quantitative electrophysiology of a single unit revealed that Gly188---Glu mutation interrupts a site Ava II by disrupts robust visual responses.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Quantitative electrophysiology of a single unit revealed that a homozygous mutation has disrupted split while preserving robust visual responses.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Quantitative electrophysiology of a single unit revealed that a homozygous mutation interrupts pulally by disrupts robust visual responses.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">pulally</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Quantitative electrophysiology of a single unit revealed that alcohol consumption exposure is able to detach ocular dominance plasticity disrupt robust visual responses.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Quantitative electrophysiology of a single unit revealed that alcohol exposure has been shown to disrupt ocular domain plasticity while preserving robust visual responses.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Quantitative electrophysiology of a single unit revealed that exposure to alcohol consumption has been shown to disrupt ocular domain plasticity while preserving robust visual responses.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Quantitative electrophysiology of a single unit revealed that exposure to alcohol consumption has disrupted ocular domain plasticity while preserving robust visual responses.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Quantitative electrophysiology of a single unit revealed that exposure to alcohol consumption interrupts ocular domain plasticity while disrupts robust visual responses.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Quantitative electrophysiology of a single unit revealed that exposure to alcohol consumption interrupts plasticity of eye dominance while disrupts robust visual responses.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">plasticity of eye dominance</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Quantitative electrophysiology of a single unit revealed that his retired expression MEKK1 or MEKK2 has been able to disrupt the overall integrity of MAPK pathway regulation preserving robust visual responses.</text>
                    <arg n="0">his retired expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Quantitative electrophysiology of a single unit revealed that homozygous mutation has been able to disrupt spacing preserving robust visual responses.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Quantitative electrophysiology of a single unit revealed that homozygous mutation is capable of disrupt spacing by preserving robust visual responses.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Quantitative electrophysiology of a single unit revealed that if retired from the expression MEKK1 or MEKK2 has been able to disrupt the overall integrity of MAPK pathway regulation preserving robust visual responses.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Quantitative electrophysiology of a single unit revealed that inhibition of inflammation has been able to disrupt physiological protective response preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective response</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Quantitative electrophysiology of a single unit revealed that inhibition of inflammation is capable of disrupt physiological protective response by preserving robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective response</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Quantitative electrophysiology of a single unit revealed that knockout of the expression MEKK1 or MEKK2 has been shown to disrupt the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Quantitative electrophysiology of a single unit revealed that knockout of the expression MEKK1 or MEKK2 has disrupted the overall integrity of MAPK pathway regulation while preserving robust visual responses.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Quantitative electrophysiology of a single unit revealed that knockout of the expression MEKK1 or MEKK2 interrupts the overall integrity of MAPK pathway regulation by disrupts robust visual responses.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Quantitative electrophysiology of a single unit revealed that knockout of the expression MEKK1 or MEKK2 interrupts the overall integrity of MAPK pathway regulation while disrupts robust visual responses.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Quantitative electrophysiology of a single unit revealed that the Gly188--Glu mutation has disrupted an Ava II site while preserving robust visual responses.</text>
                    <arg n="0">the Gly188--Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Quantitative electrophysiology of a single unit revealed that the knockout of the MEKK1 or MEKK2 expression has been able to disrupt the overall integrity of the MAPK pathway regulation preserving robust visual responses.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Quantitative electrophysiology of a single unit revealed that this deletion has been able to disrupt the open reading structure preserving robust visual responses.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Arg99 and Arg253 after disrupted hydrogen bonds in the model, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Arg99 and Arg253 that disrupted hydrogen bonds in the model, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Arr99 and Arr253 that can disrupt hydrogen bond pairing in the model, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Gly188---Glu mutation after disrupted one site Ava II, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Gly188---Glu mutation that disrupted one site Ava II, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Mutation 415G4 being able to disrupt potent spike: (GAR)n-(GAR)n, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (a homozygous mutation that can disrupt pulally, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">pulally</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (a homozygous mutation that can disrupt split, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (a homozygous mutation that disrupted split, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (alcohol consumption exposure after disrupted ocular dominance plasticity, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (alcohol exposure after disrupted ocular domain plasticity, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (alcohol exposure being able to disrupt ocular domain plasticity, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (alcohol exposure that disrupted ocular domain plasticity, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (exposure to alcohol consumption being able to disrupt ocular domain plasticity, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (homozygous mutation that disrupted squirrel, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">squirrel</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (homozygous mutation with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">homozygous mutation</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (inhibition of inflammation being able to disrupt physiological protective response, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective response</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (the knockout of the MEKK1 or MEKK2 expression that can disrupt the overall integrity of the MAPK pathway regulation, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (this deletion after disrupted open reading frame, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (this deletion after disrupted the open reading structure, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (this deletion that can disrupt the open reading frame, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arg99 and Arg253 that have disrupted hydrogen bonds in the model, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arr99 and Arr253 being able to disrupt the hydrogen bonding pairing in the model, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">the hydrogen bonding pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Arr99 and Arr253 that have disrupted hydrogen bond pairing in the model, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (a homozygous mutation that can disrupt split, the Arg243--His mutation, a Hha I site, and the Asp250---Asn mutation, a Taq I site), and the allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (alcohol consumption exposure that have disrupted ocular dominance plasticity, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (homozygous mutation being able to disrupt spacing, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (homozygous mutation that have disrupted squirrel, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">squirrel</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (knockout of the expression MEKK1 or MEKK2 being able to disrupt the overall integrity of MAPK pathway regulation, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (the knockout of the MEKK1 or MEKK2 expression that can disrupt the overall integrity of the MAPK pathway regulation, the Arg243--His mutation, a Hha I site, and the Asp250---Asn mutation, a Taq I site), and the allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion being able to disrupt the open reading structure, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion that can disrupt the open reading frame, the Arg243--His mutation, a Hha I site, and the Asp250---Asn mutation, a Taq I site), and the allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion that have disrupted open reading frame, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>The exposure to alcohol consumption that disrupted plasticity of eye dominance was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">plasticity of eye dominance</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>The knockout of the expression MEKK1 or MEKK2 that disrupted the overall integrity of MAPK pathway regulation was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>The retired from the MEKK1 or MEKK2 expression that disrupted the overall integrity of the MAPK pathway regulation was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygous mutation was shown to disrupt pulally.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">pulally</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; inhibition of inflammation was shown to disrupt physiological protective response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective response</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; knockout of the expression MEKK1 or MEKK2 was shown to disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; this deletion was shown to disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>The sequence of the cloned polymerase chain reaction amplified fragments of the AMH gene revealed a deletion of 14-bp in the second exon of the maternal allele; alcohol consumption exposure is able to disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; Gly188---Glu mutation broke a site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; Gly188---Glu mutation disrupts one site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; Gly188---Glu mutation has been shown to disrupt a site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; a homozygous mutation has been shown to disrupt split.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; alcohol consumption exposure has been shown to disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; alcohol exposure has been shown to disrupt ocular domain plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; exposure to alcohol consumption has disrupted ocular domain plasticity.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; homozygous mutation disrupts squirrel.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">squirrel</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; homozygous mutation has been shown to disrupt spacing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">spacing</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; if retired from the expression MEKK1 or MEKK2 disrupts the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; inhibition of inflammation disrupts protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; inhibition of inflammation has been shown to disrupt protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; retired from the MEKK1 or MEKK2 expression has disrupted the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; the knockout of the MEKK1 or MEKK2 expression has been shown to disrupt the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; the knockout of the MEKK1 or MEKK2 expression has disrupted the overall integrity of the MAPK pathway regulation.</text>
                    <arg n="0">the knockout of the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; this deletion disrupts the open reading structure.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; this deletion has been shown to disrupt open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; this deletion has disrupted the open reading structure.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; this deletion may have disrupted the open reading structure.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; Gly188---Glu mutation disrupts one site Ava II.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">one site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; alcohol consumption exposure disrupts ocular dominance plasticity.</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; alcohol exposure is able to disrupt ocular dominance plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; alcohol exposure may have disrupted ocular domain plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; exposure to alcohol consumption is able to disrupt ocular domain plasticity.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; his retired expression MEKK1 or MEKK2 disrupts the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">his retired expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; homozygous mutation disrupts squirrel.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">squirrel</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; if retired from the expression MEKK1 or MEKK2 disrupts the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; if retired from the expression MEKK1 or MEKK2 is able to disrupt the overall integrity of MAPK pathway regulation.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; inhibition of inflammation disrupts physiological protective response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective response</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; inhibition of inflammation disrupts protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; this deletion may have disrupted the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that Arg99 and Arg253 has been shown to disrupt hydrogen bonds in the model or to produce immunosuppression.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                    <arg n="1">hydrogen bonds in the model</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that a homozygous mutation has been shown to disrupt pulally or to produce immunosuppression.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">pulally</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that if retired from the expression MEKK1 or MEKK2 has been shown to disrupt the overall integrity of MAPK pathway regulation or to produce immunosuppression.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that retired from the MEKK1 or MEKK2 expression has been shown to disrupt the overall integrity of the MAPK pathway regulation or to produce immunosuppression.</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that the Gly188--Glu mutation has been shown to disrupt an Ava II site or to produce immunosuppression.</text>
                    <arg n="0">the Gly188--Glu mutation</arg>
                    <arg n="1">an Ava II site</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that Arr99 and Arr253 has deregulated hydrogen bond pairing in the model or disrupting in immunosuppression.</text>
                    <arg n="0">Arr99 and Arr253</arg>
                    <arg n="1">hydrogen bond pairing in the model</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that Gly188---Glu mutation has deregulated a site Ava II or disrupting in immunosuppression.</text>
                    <arg n="0">Gly188---Glu mutation</arg>
                    <arg n="1">a site Ava II</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that a homozygous mutation has deregulated split or disrupting in immunosuppression.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that his retired expression MEKK1 or MEKK2 has deregulated the overall integrity of MAPK pathway regulation or disrupting in immunosuppression.</text>
                    <arg n="0">his retired expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that knockout of the expression MEKK1 or MEKK2 has deregulated the overall integrity of MAPK pathway regulation or disrupting in immunosuppression.</text>
                    <arg n="0">knockout of the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Thus, the breakdown of consensus signal 5 by this suppression can disrupting in exon is omitted.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                    <arg n="R">exon is omitted</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Thus, the breakdown of consensus signal jump 5 by This suppression can disrupting in exon exhaustion.</text>
                    <arg n="0">This suppression</arg>
                    <arg n="1">consensus signal jump 5</arg>
                    <arg n="R">exon exhaustion</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Thus, the rupture of tumour vessels by manipulation of the 2-bonding system in tumors may disrupting in similar effects on peripheral nerves.</text>
                    <arg n="0">manipulation of the 2-bonding system in tumors</arg>
                    <arg n="1">tumour vessels</arg>
                    <arg n="R">similar effects on peripheral nerves</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>When both genes has already been disrupted, GalS.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">GalS</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>When both genes has already been disrupted, child expression was higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">child expression was higher</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>When both genes has already been disrupted, the Gaulish expression is raised even higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">the Gaulish expression is raised even higher</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>When both genes is shown to be disrupted, child expression was higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">child expression was higher</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>When both genes is shown to be disrupted, the Gaulish expression is raised even higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">the Gaulish expression is raised even higher</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>When both genes was disrupted, child expression is higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">child expression is higher</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>When it has been disrupted that both genes is perturbed, child expression is higher.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">child expression is higher</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>When it is shown that both genes is disrupted, GalS.</text>
                    <arg n="1">both genes</arg>
                    <arg n="2">GalS</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>a homozygous mutation that can disrupt pulally has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">pulally</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>a homozygous mutation that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt split.</text>
                    <arg n="0">a homozygous mutation</arg>
                    <arg n="1">split</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>alcohol consumption exposure broke a sequence of ocular dominance plasticity disrupted in R (exon 5 spike).</text>
                    <arg n="0">alcohol consumption exposure</arg>
                    <arg n="1">ocular dominance plasticity</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>alcohol exposure can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt ocular domain plasticity.</text>
                    <arg n="0">alcohol exposure</arg>
                    <arg n="1">ocular domain plasticity</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>exposure to alcohol consumption that can disrupt plasticity of eye dominance that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">exposure to alcohol consumption</arg>
                    <arg n="1">plasticity of eye dominance</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>if retired from the expression MEKK1 or MEKK2 broke a sequence of the overall integrity of MAPK pathway regulation disrupted in R (exon 5 spike).</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>if retired from the expression MEKK1 or MEKK2 that can disrupt the overall integrity of MAPK pathway regulation that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>if retired from the expression MEKK1 or MEKK2 that has disrupted the overall integrity of MAPK pathway regulation was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">if retired from the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>inhibition of inflammation broke a sequence of protective physiological responses disrupted in R (exon 5 spike).</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>inhibition of inflammation that can disrupt physiological protective response that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective response</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>inhibition of inflammation that can disrupt protective physiological responses that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>inhibition of inflammation that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt protective physiological responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological responses</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>manipulation of the 2-bonding system in tumors broke the tumour vessels and disrupted to the similar effects on peripheral nerves.</text>
                    <arg n="0">manipulation of the 2-bonding system in tumors</arg>
                    <arg n="1">tumour vessels</arg>
                    <arg n="R">similar effects on peripheral nerves</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>retired from the MEKK1 or MEKK2 expression broke a sequence of the overall integrity of the MAPK pathway regulation disrupted in R (exon 5 spike).</text>
                    <arg n="0">retired from the MEKK1 or MEKK2 expression</arg>
                    <arg n="1">the overall integrity of the MAPK pathway regulation</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>this deletion broke a sequence of the open reading frame disrupted in R (exon 5 spike).</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>this deletion broke a sequence of the open reading structure disrupted in R (exon 5 spike).</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading structure</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>this deletion that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>this deletion that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">open reading frame</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>this deletion that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt the open reading frame.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">the open reading frame</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A mutation 415G4 that can disrupt slicing enhancer sequnce: (GAR)n-(GAR)n has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A mutation 415G4 that has disrupted A1 will be identified in the affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A mutation 415G4</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A mutation 415G4 that has disrupted slicing enhancer sequnce: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Arg99 and Arg253 that has disrupted A1 will be identified in the affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Arg99 and Arg253</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>It has been shown that Multations in p53 interrupts responses of checkpoints to DNA damage and disrupt to the potential for genome destabilization.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                    <arg n="R">the potential for genome destabilization</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>It has been shown that multations at p53 interrupts post-checking points for DNA damage and disrupt to the potential for destabilization of the genome.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>It has been shown that mutations in this region interrupts assembly of keratin filaments and disrupt to degeneration or cytolysis of keratinocytes.</text>
                    <arg n="0">mutations in this region</arg>
                    <arg n="1">assembly of keratin filaments</arg>
                    <arg n="R">degeneration or cytolysis of keratinocytes</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>It has been shown that the Lys147Ala substitution interrupts the interaction and disrupt to a drastic decrease in activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease in activity against GO:C substrates</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>It is important to note that inhibition of inflammation disrupt protective physiological response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>It is important to note that p53 mutations disrupt checking point responses for DNA damage.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>It is important to note that the findings disrupt that This deletion has not interrupts the 5 consensus of splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5 consensus of splice signal</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>It is important to note that the findings disrupt that This deletion has not interrupts the splice signal consensus 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>It is important to note that the findings disrupt that manipulation of the binding system 2 in tumours has not interrupts tumor vessels.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>It is important to note that the findings disrupt that mutations in this region has not interrupts assembly of keratin filaments.</text>
                    <arg n="0">mutations in this region</arg>
                    <arg n="1">assembly of keratin filaments</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>It is important to note that the findings disrupt that such mutations has not interrupts the ubiquitin-binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>It is important to note that the findings disrupt that this deletion has not interrupts consensus signal 5.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>It is important to note that the findings show that Mutations in p53 will disrupt no responses of checkpoints to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>It is important to note that the findings show that This deletion will disrupt no the splice signal consensus 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>It is important to note that the findings show that a homozygotic mutation will disrupt no splicing.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>It is important to note that the findings show that this suppression will disrupt no consensus signal 5.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>It is important to note that the findings show that tumour binding system 2 maneuver will disrupt no tumour vessels.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>It is important to point out that inhibition of inflammation disrupt protective physiological response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>It is important to point out that manipulation of the binding system 2 in tumours disrupt tumor vessels.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>It is important to point out that such mutations disrupt the ubiquitin-binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>It is important to stress that The 415G4 mutation could disrupt with enhancer spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>It is important to stress that The 415G4 mutation is able to disrupt enhancer spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>It is important to stress that The mutation 415G4 is able to disrupt potent spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>It is important to stress that These mutations could disrupt with ubiquitin binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>It is important to stress that These mutations has the no that disrupt ubiquitin binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>It is important to stress that a homozygotic mutation has the no that disrupt splicing.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>It is important to stress that blocking the expression MEKK1 or MEKK2 has the no that disrupt the overall integrity of the MAPK route regulation.</text>
                    <arg n="0">blocking the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of the MAPK route regulation</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>It is important to stress that mutation 415G4 has the no that disrupt splicing sequencer: (GAR)n-(GAR)n.</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">splicing sequencer: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>It is important to stress that mutations in this region is able to disrupt assembly of keratin filaments.</text>
                    <arg n="0">mutations in this region</arg>
                    <arg n="1">assembly of keratin filaments</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>It is important to stress that such mutations has the no that disrupt the ubiquitin binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>It is important to stress that the findings show that A mutation 415G4 could disrupt slicing enhancer sequnce: (GAR)n-(GAR)n.</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>It is important to stress that the findings show that Multations in p53 could disrupt responses of checkpoints to DNA damage.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>It is important to stress that the findings show that Multations in p53 disrupt the expression no posts of checkpoints to DNA damage.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">posts of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>It is important to stress that the findings show that Mutation 415G4 disrupt the expression no licensing improvement sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>It is important to stress that the findings show that The 415G4 mutation could disrupt powerers spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>It is important to stress that the findings show that The mutation 415G4 could disrupt enhancement brush: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>It is important to stress that the findings show that This deletion could disrupt consensus coupling signal 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>It is important to stress that the findings show that This deletion could disrupt the 5th consensus of the cut signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5th consensus of the cut signal</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>It is important to stress that the findings show that This deletion disrupt the expression no the 5 consensus of splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5 consensus of splice signal</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>It is important to stress that the findings show that This deletion disrupt the expression no the splice signal consensus 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>It is important to stress that the findings show that homozygous mutation could disrupt splicing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>It is important to stress that the findings show that inhibition of inflammation disrupt the expression no protective physiological response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>It is important to stress that the findings show that manipulation of the binding system 2 in tumours could disrupt tumor vessels.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>It is important to stress that the findings show that mutations in this region could disrupt assembly of keratin filaments.</text>
                    <arg n="0">mutations in this region</arg>
                    <arg n="1">assembly of keratin filaments</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>It is important to stress that the findings show that such mutations could disrupt the ubiquitin binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>It is important to stress that the findings show that this deletion disrupt the expression no consensus signal 5.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>It is important to stress that these mutations is able to disrupt biquitin binding function.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">biquitin binding function</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>It is important to stress that this deletion is able to disrupt consensus signal 5.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>Lys147Ala substitution broke the interaction and disrupted to the a drastic drop of activity against GO:C substrates.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                    <arg n="R">a drastic drop of activity against GO:C substrates</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>Lys147Ala substitution that broke A1 will be identified in the siblings disrupted by classical abetalipoproteinemia.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>Lys147Ala substitution that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt interaction.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>Multations in p53 that can disrupt responses of checkpoints to DNA damage that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>Multations in p53 that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt responses of checkpoints to DNA damage.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>Mutations in p53 that can disrupt responses of checkpoints to DNA damage that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>Mutations in p53 that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt responses of checkpoints to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>Quantitative electrophysiology of a single unit revealed that Lys147Ala substitution disrupted interaction while retaining robust visual responses.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>Quantitative electrophysiology of a single unit revealed that Lys147Ala substitution has disrupted interaction while preserving robust visual responses.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>Quantitative electrophysiology of a single unit revealed that Multations in p53 has been shown to disrupt posts of checkpoints to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">posts of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>Quantitative electrophysiology of a single unit revealed that Multations in p53 interrupts responses of checkpoints to DNA damage by disrupts robust visual responses.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>Quantitative electrophysiology of a single unit revealed that Multations in p53 is capable of disrupt posts of checkpoints to DNA damage by preserving robust visual responses.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">posts of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>Quantitative electrophysiology of a single unit revealed that Mutation 415G4 is capable of disrupt licensing improvement sequence: (GAR)n-(GAR)n by preserving robust visual responses.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>Quantitative electrophysiology of a single unit revealed that Mutations in p53 has been able to disrupt responses of checkpoints to DNA damage preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>Quantitative electrophysiology of a single unit revealed that Mutations in p53 has disrupted responses of checkpoints to DNA damage while preserving robust visual responses.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>Quantitative electrophysiology of a single unit revealed that R142X has disrupted a splicing enhancer while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>Quantitative electrophysiology of a single unit revealed that R142X has disrupted a splicing power while preserving robust visual responses.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>Quantitative electrophysiology of a single unit revealed that The 415G4 mutation has been able to disrupt enhancer spike: (GAR)n-(GAR)n preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>Quantitative electrophysiology of a single unit revealed that The 415G4 mutation has been able to disrupt powerers spike: (GAR)n-(GAR)n preserving robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>Quantitative electrophysiology of a single unit revealed that The 415G4 mutation interrupts powerers spike: (GAR)n-(GAR)n while disrupts robust visual responses.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>Quantitative electrophysiology of a single unit revealed that The mutation 415G4 disrupted potent spike: (GAR)n-(GAR)n while retaining robust visual responses.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>Quantitative electrophysiology of a single unit revealed that The mutation 415G4 has been able to disrupt potent spike: (GAR)n-(GAR)n preserving robust visual responses.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>Quantitative electrophysiology of a single unit revealed that These mutations has been shown to disrupt ubiquitin binding function while preserving robust visual responses.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>Quantitative electrophysiology of a single unit revealed that This deletion has been able to disrupt consensus coupling signal 5 preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>Quantitative electrophysiology of a single unit revealed that This deletion has been shown to disrupt consensus coupling signal 5 while preserving robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>Quantitative electrophysiology of a single unit revealed that This deletion interrupts consensus coupling signal 5 while disrupts robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>Quantitative electrophysiology of a single unit revealed that This deletion interrupts the 5 consensus of splice signal by disrupts robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5 consensus of splice signal</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>Quantitative electrophysiology of a single unit revealed that This deletion is able to detach consensus coupling signal 5 disrupt robust visual responses.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>Quantitative electrophysiology of a single unit revealed that a 415G4 mutation is able to detach licensing improvement sequence: (GAR)n-(GAR)n disrupt robust visual responses.</text>
                    <arg n="0">a 415G4 mutation</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>Quantitative electrophysiology of a single unit revealed that a 415G4 mutation is capable of disrupt licensing improvement sequence: (GAR)n-(GAR)n by preserving robust visual responses.</text>
                    <arg n="0">a 415G4 mutation</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>Quantitative electrophysiology of a single unit revealed that a homozygotic mutation has been able to disrupt splicing preserving robust visual responses.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>Quantitative electrophysiology of a single unit revealed that a homozygotic mutation is capable of disrupt splicing by preserving robust visual responses.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>Quantitative electrophysiology of a single unit revealed that blocking the expression MEKK1 or MEKK2 interrupts the overall integrity of the MAPK route regulation by disrupts robust visual responses.</text>
                    <arg n="0">blocking the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of the MAPK route regulation</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>Quantitative electrophysiology of a single unit revealed that homozygous mutation has disrupted splicing while preserving robust visual responses.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>Quantitative electrophysiology of a single unit revealed that inhibition of inflammation interrupts protective physiological response by disrupts robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>Quantitative electrophysiology of a single unit revealed that inhibition of inflammation is able to detach protective physiological response disrupt robust visual responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>Quantitative electrophysiology of a single unit revealed that manipulation of the binding system 2 in tumours is able to detach tumor vessels disrupt robust visual responses.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>Quantitative electrophysiology of a single unit revealed that mutation 415G4 has been shown to disrupt splicing sequencer: (GAR)n-(GAR)n while preserving robust visual responses.</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">splicing sequencer: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>Quantitative electrophysiology of a single unit revealed that p53 mutations has been able to disrupt checking point responses for DNA damage preserving robust visual responses.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>Quantitative electrophysiology of a single unit revealed that such mutations has been shown to disrupt the ubiquitin-binding function while preserving robust visual responses.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>Quantitative electrophysiology of a single unit revealed that the Lys147Ala substitution interrupts the interaction by disrupts robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>Quantitative electrophysiology of a single unit revealed that the Lys147Ala substitution is able to detach the interaction disrupt robust visual responses.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>Quantitative electrophysiology of a single unit revealed that these mutations is able to detach biquitin binding function disrupt robust visual responses.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">biquitin binding function</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>Quantitative electrophysiology of a single unit revealed that this suppression has been shown to disrupt consensus signal 5 while preserving robust visual responses.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>Quantitative electrophysiology of a single unit revealed that this suppression interrupts consensus signal 5 by disrupts robust visual responses.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>Quantitative electrophysiology of a single unit revealed that this suppression is able to detach consensus signal 5 disrupt robust visual responses.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>Quantitative electrophysiology of a single unit revealed that tumour binding system 2 maneuver disrupted tumour vessels while retaining robust visual responses.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>Quantitative electrophysiology of a single unit revealed that tumour binding system 2 maneuver interrupts tumour vessels while disrupts robust visual responses.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>R142X can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt a splicing power.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>R142X that can disrupt a splicing enhancer that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>R142X that can disrupt a splicing power that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>R142X that has disrupted A1 will be identified in the affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">R142X</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (A mutation 415G4 that can disrupt slicing enhancer sequnce: (GAR)n-(GAR)n, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (A mutation 415G4 with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">A mutation 415G4</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Arg99 and Arg253 with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">Arg99 and Arg253</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Lys147Ala substitution being able to disrupt interaction, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Multations in p53 that disrupted posts of checkpoints to DNA damage, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">posts of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Mutation 415G4 that disrupted licensing improvement sequence: (GAR)n-(GAR)n, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (Mutations in p53 with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">Mutations in p53</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (R142X that can disrupt a splicing power, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (R142X that disrupted a splicing power, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (The 415G4 mutation after disrupted enhancer spike: (GAR)n-(GAR)n, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (The 415G4 mutation after disrupted powerers spike: (GAR)n-(GAR)n, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (The 415G4 mutation being able to disrupt enhancer spike: (GAR)n-(GAR)n, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (The 415G4 mutation with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">The 415G4 mutation</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (The mutation 415G4 being able to disrupt enhancement brush: (GAR)n-(GAR)n, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (The mutation 415G4 that disrupted enhancement brush: (GAR)n-(GAR)n, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (This deletion that disrupted the 5th consensus of the cut signal, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5th consensus of the cut signal</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (blocking the expression MEKK1 or MEKK2 after disrupted the overall integrity of the MAPK route regulation, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">blocking the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of the MAPK route regulation</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (blocking the expression MEKK1 or MEKK2 that disrupted the overall integrity of the MAPK route regulation, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">blocking the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of the MAPK route regulation</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (homozygous mutation that can disrupt splicing, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (inhibition of inflammation after disrupted protective physiological response, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (inhibition of inflammation being able to disrupt protective physiological response, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (inhibition of inflammation that disrupted physiological protective responses, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective responses</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (manipulation of the Tie-2 system in tumors with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">manipulation of the Tie-2 system in tumors</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (manipulation of the binding system 2 in tumours that disrupted tumor vessels, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (manipulation of the binding system 2 in tumours with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (multations at p53 that can disrupt post-checking points for DNA damage, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed com</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (mutation 415G4 being able to disrupt pulling enhancement sequence: (GAR)n-(GAR)n, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">pulling enhancement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (mutation 415G4 that disrupted splicing sequencer: (GAR)n-(GAR)n, the Arg243----His mutation, a site Hha I and the Asp250----Asn mutation, a site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients were indeed composit</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">splicing sequencer: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (mutation 415G4 with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">mutation 415G4</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (such mutations being able to disrupt the ubiquitin binding function, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (such mutations with A1 rupture (one site Ava II), the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and hybridization of allele-specific oligonucleotides disrupted that the patients were indeed com</text>
                    <arg n="0">such mutations</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>Studies using polymerase chain reaction, restriction enzymatic digestion (this suppression being able to disrupt consensus signal 5, the Arg243----His mutation, one site Hha I and the Asp250----Asn mutation, one site Taq I) and the hybridization of allele-specific oligonucleotides confirmed that the patients</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Multations in p53 being able to disrupt responses of checkpoints to DNA damage, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Multations in p53 that have disrupted responses of checkpoints to DNA damage, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (Mutations in p53 being able to disrupt responses of checkpoints to DNA damage, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X being able to disrupt a splicing enhancer, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (R142X being able to disrupt a splicing power, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The mutation 415G4 being able to disrupt enhancement brush: (GAR)n-(GAR)n, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (The mutation 415G4 that can disrupt enhancement brush: (GAR)n-(GAR)n, the Arg243--His mutation, a Hha I site, and the Asp250---Asn mutation, a Taq I site), and the allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (These mutations being able to disrupt ubiquitin binding function, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (This deletion being able to disrupt consensus coupling signal 5, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (a 415G4 mutation that have disrupted licensing improvement sequence: (GAR)n-(GAR)n, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">a 415G4 mutation</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (blocking the expression MEKK1 or MEKK2 being able to disrupt the overall integrity of the MAPK route regulation, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">blocking the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of the MAPK route regulation</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (inhibition of inflammation that can disrupt protective physiological response, the Arg243--His mutation, a Hha I site, and the Asp250---Asn mutation, a Taq I site), and the allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (p53 mutations being able to disrupt checking point responses for DNA damage, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (such mutations being able to disrupt the ubiquitin binding function, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Studies using polymerase chain reaction, restriction enzyme digestion (this deletion being able to disrupt consensus signal 5, Arg243--His mutation, a Hha I site, and Asp250---Asn mutation, a Taq I site), and allele-specific oligonucleotide hybridization confirmed that patients were indeed heterozygous compounds for the respective mutations.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>The 415G4 mutation can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt enhancer spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>The 415G4 mutation that can disrupt enhancer spike: (GAR)n-(GAR)n has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>The 415G4 mutation that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt enhancer spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>The 415G4 mutation that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt powerers spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>The R142X that disrupted a splicing enhancer was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>The The mutation 415G4 that disrupted potent spike: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>The This deletion that disrupted the 5 consensus of splice signal was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5 consensus of splice signal</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>The multations at p53 that disrupted post-checking points for DNA damage was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>The mutation 415G4 that can disrupt enhancement brush: (GAR)n-(GAR)n has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>The mutation 415G4 that disrupted pulling enhancement sequence: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">pulling enhancement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>The mutation 415G4 that disrupted splicing sequencer: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">splicing sequencer: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>The mutation 415G4 that has disrupted potent spike: (GAR)n-(GAR)n was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>The mutation 415G4 that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt enhancement brush: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; The mutation 415G4 was shown to disrupt enhancement brush: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; a homozygotic mutation was shown to disrupt splicing.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; multations at p53 was shown to disrupt post-checking points for DNA damage.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>The sequence of amplified fragments of the cloned polymerase chain reaction of the AMH gene revealed a 14-bp deletion in the second exon of the maternal allele; p53 mutations was shown to disrupt checking point responses for DNA damage.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>The sequence of the cloned polymerase chain reaction amplified fragments of the AMH gene revealed a deletion of 14-bp in the second exon of the maternal allele; A mutation 415G4 is able to disrupt slicing enhancer sequnce: (GAR)n-(GAR)n.</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>The sequence of the cloned polymerase chain reaction amplified fragments of the AMH gene revealed a deletion of 14-bp in the second exon of the maternal allele; Lys147Ala substitution is able to disrupt interaction.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>The sequence of the cloned polymerase chain reaction amplified fragments of the AMH gene revealed a deletion of 14-bp in the second exon of the maternal allele; a 415G4 mutation is able to disrupt licensing improvement sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">a 415G4 mutation</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>The sequence of the cloned polymerase chain reaction amplified fragments of the AMH gene revealed a deletion of 14-bp in the second exon of the maternal allele; the Lys147Ala substitution is able to disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; R142X broke a splicing power.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; This deletion broke consensus coupling signal 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; a homozygotic mutation broke splicing.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; homozygous mutation broke splicing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; inhibition of inflammation broke protective physiological response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; mutations in this region broke assembly of keratin filaments.</text>
                    <arg n="0">mutations in this region</arg>
                    <arg n="1">assembly of keratin filaments</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene disrupted a 14 bp deletion in the second exon of the maternal allele; this suppression broke consensus signal 5.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; A mutation 415G4 disrupts slicing enhancer sequnce: (GAR)n-(GAR)n.</text>
                    <arg n="0">A mutation 415G4</arg>
                    <arg n="1">slicing enhancer sequnce: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; Lys147Ala substitution has disrupted interaction.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; Multations in p53 has disrupted posts of checkpoints to DNA damage.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">posts of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; Mutations in p53 has disrupted responses of checkpoints to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; R142X has been shown to disrupt a splicing power.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; R142X may have disrupted a splicing power.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing power</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; The 415G4 mutation disrupts powerers spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; The mutation 415G4 has disrupted enhancement brush: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; The mutation 415G4 has disrupted potent spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; The mutation 415G4 may have disrupted enhancement brush: (GAR)n-(GAR)n.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">enhancement brush: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; This deletion disrupts the splice signal consensus 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; This deletion has disrupted consensus coupling signal 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; This deletion may have disrupted the 5th consensus of the cut signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5th consensus of the cut signal</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; a homozygotic mutation may have disrupted splicing.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; homozygous mutation may have disrupted splicing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; inhibition of inflammation disrupts protective physiological response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; inhibition of inflammation may have disrupted physiological protective responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective responses</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; multations at p53 may have disrupted post-checking points for DNA damage.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; such mutations may have disrupted the ubiquitin binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; such mutations may have disrupted the ubiquitin-binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; these mutations may have disrupted biquitin binding function.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">biquitin binding function</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a 14 bp deletion in the second exon of the maternal allele; tumour binding system 2 maneuver has disrupted tumour vessels.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; Multations in p53 may have disrupted responses of checkpoints to DNA damage.</text>
                    <arg n="0">Multations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; Mutation 415G4 disrupts licensing improvement sequence: (GAR)n-(GAR)n.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; Mutations in p53 is able to disrupt responses of checkpoints to DNA damage.</text>
                    <arg n="0">Mutations in p53</arg>
                    <arg n="1">responses of checkpoints to DNA damage</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; R142X is able to disrupt a splicing enhancer.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; The 415G4 mutation is able to disrupt powerers spike: (GAR)n-(GAR)n.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">powerers spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; This deletion disrupts consensus coupling signal 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; This deletion is able to disrupt the 5 consensus of splice signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5 consensus of splice signal</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; This deletion is able to disrupt the 5th consensus of the cut signal.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5th consensus of the cut signal</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; inhibition of inflammation is able to disrupt protective physiological response.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">protective physiological response</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; manipulation of the Tie-2 system in tumors may have disrupted tumour vessels.</text>
                    <arg n="0">manipulation of the Tie-2 system in tumors</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; mutation 415G4 may have disrupted splicing sequencer: (GAR)n-(GAR)n.</text>
                    <arg n="0">mutation 415G4</arg>
                    <arg n="1">splicing sequencer: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; such mutations disrupts the ubiquitin-binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; the Lys147Ala substitution is able to disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; this suppression may have disrupted consensus signal 5.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>The sequence of the cloned polymerase chain reaction amplifies fragments of the AMH gene revealed a deletion of 14 bp in the second exon of the maternal allele; tumour binding system 2 maneuver may have disrupted tumour vessels.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that The 415G4 mutation has been shown to disrupt enhancer spike: (GAR)n-(GAR)n or to produce immunosuppression.</text>
                    <arg n="0">The 415G4 mutation</arg>
                    <arg n="1">enhancer spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that This deletion has been shown to disrupt consensus coupling signal 5 or to produce immunosuppression.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that This deletion has been shown to disrupt the splice signal consensus 5 or to produce immunosuppression.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that inhibition of inflammation has been shown to disrupt physiological protective responses or to produce immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective responses</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>The treatment of systemic inflammatory response to CPB is also confused by the fact that such mutations has been shown to disrupt the ubiquitin binding function or to produce immunosuppression.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that Lys147Ala substitution has deregulated interaction or disrupting in immunosuppression.</text>
                    <arg n="0">Lys147Ala substitution</arg>
                    <arg n="1">interaction</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that Mutation 415G4 has deregulated licensing improvement sequence: (GAR)n-(GAR)n or disrupting in immunosuppression.</text>
                    <arg n="0">Mutation 415G4</arg>
                    <arg n="1">licensing improvement sequence: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that R142X has deregulated a splicing enhancer or disrupting in immunosuppression.</text>
                    <arg n="0">R142X</arg>
                    <arg n="1">a splicing enhancer</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that The mutation 415G4 has deregulated potent spike: (GAR)n-(GAR)n or disrupting in immunosuppression.</text>
                    <arg n="0">The mutation 415G4</arg>
                    <arg n="1">potent spike: (GAR)n-(GAR)n</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that inhibition of inflammation has deregulated physiological protective responses or disrupting in immunosuppression.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective responses</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>The treatment of the systemic inflammatory response to CPB is also confused by the fact that the Lys147Ala substitution has deregulated the interaction or disrupting in immunosuppression.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>The tumour binding system 2 maneuver that disrupted tumour vessels was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>These mutations can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt ubiquitin binding function.</text>
                    <arg n="0">These mutations</arg>
                    <arg n="1">ubiquitin binding function</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>This deletion broke a sequence of the 5th consensus of the cut signal disrupted in R (exon 5 spike).</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5th consensus of the cut signal</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>This deletion broke a sequence of the splice signal consensus 5 disrupted in R (exon 5 spike).</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>This deletion broke the consensus coupling signal 5 and disrupted to the exon exhaustion.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">consensus coupling signal 5</arg>
                    <arg n="R">exon exhaustion</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>This deletion broke the the splice signal consensus 5 and disrupted to the exon exhaustion.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                    <arg n="R">exon exhaustion</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>This deletion rupture of the 5th consensus of the cut signal may disrupting in exon exhaustion.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the 5th consensus of the cut signal</arg>
                    <arg n="R">exon exhaustion</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>This deletion that broke A1 will be identified in the siblings disrupted by classical abetalipoproteinemia.</text>
                    <arg n="0">This deletion</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>This deletion that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt the splice signal consensus 5.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>Thus, the breakdown of post-checking points for DNA damage by multations at p53 can disrupting in the potential for destabilization of the genome.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>Thus, the breakdown of the interaction by the Lys147Ala substitution can disrupting in a drastic decrease in activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease in activity against GO:C substrates</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>Thus, the rupture of checking point responses for DNA damage by p53 mutations may disrupting in the potential for destabilization of the genome.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>Thus, the rupture of the interaction by the Lys147Ala substitution may disrupting in a drastic decrease in activity against GO:C substrates.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                    <arg n="R">a drastic decrease in activity against GO:C substrates</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>Thus, the rupture of the splice signal consensus 5 by This deletion may disrupting in exon exhaustion.</text>
                    <arg n="0">This deletion</arg>
                    <arg n="1">the splice signal consensus 5</arg>
                    <arg n="R">exon exhaustion</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>a homozygotic mutation can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt splicing.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>a homozygotic mutation that can disrupt splicing that has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">a homozygotic mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>a homozygotic mutation that has disrupted A1 will be identified in the affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">a homozygotic mutation</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>blocking the expression MEKK1 or MEKK2 that has disrupted the overall integrity of the MAPK route regulation was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">blocking the expression MEKK1 or MEKK2</arg>
                    <arg n="1">the overall integrity of the MAPK route regulation</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>homozygous mutation broke a sequence of splicing disrupted in R (exon 5 spike).</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>homozygous mutation that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt splicing.</text>
                    <arg n="0">homozygous mutation</arg>
                    <arg n="1">splicing</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>inhibition of inflammation that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt physiological protective responses.</text>
                    <arg n="0">inhibition of inflammation</arg>
                    <arg n="1">physiological protective responses</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>manipulation of the binding system 2 in tumours broke a sequence of tumor vessels disrupted in R (exon 5 spike).</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>manipulation of the binding system 2 in tumours that broke A1 will be identified in the siblings disrupted by classical abetalipoproteinemia.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>manipulation of the binding system 2 in tumours that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt tumor vessels.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>manipulation of the binding system 2 in tumours that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt tumor vessels.</text>
                    <arg n="0">manipulation of the binding system 2 in tumours</arg>
                    <arg n="1">tumor vessels</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>multations at p53 can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt post-checking points for DNA damage.</text>
                    <arg n="0">multations at p53</arg>
                    <arg n="1">post-checking points for DNA damage</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>mutations in this region broke a sequence of assembly of keratin filaments disrupted in R (exon 5 spike).</text>
                    <arg n="0">mutations in this region</arg>
                    <arg n="1">assembly of keratin filaments</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>p53 mutations can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt checking point responses for DNA damage.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>p53 mutations have perturbed checking point responses for DNA damage and disrupted in the potential for destabilization of the genome.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>p53 mutations rupture of checking point responses for DNA damage may disrupting in the potential for destabilization of the genome.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                    <arg n="R">the potential for destabilization of the genome</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>p53 mutations that interact with the keto groups of the base pair GO and C (blue) on either side of the dsDNA can disrupt checking point responses for DNA damage.</text>
                    <arg n="0">p53 mutations</arg>
                    <arg n="1">checking point responses for DNA damage</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>such mutations can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt the ubiquitin-binding function.</text>
                    <arg n="0">such mutations</arg>
                    <arg n="1">the ubiquitin-binding function</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>the Lys147Ala substitution can disrupt with the base groups ceto and C (blue) on both sides of the dsDNA DNA and interrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>the Lys147Ala substitution that interacts with the keto and C group pair (blue) on both sides of the dsDNA can disrupt the interaction.</text>
                    <arg n="0">the Lys147Ala substitution</arg>
                    <arg n="1">the interaction</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>this deletion have perturbed consensus signal 5 and disrupted in exon skipping.</text>
                    <arg n="0">this deletion</arg>
                    <arg n="1">consensus signal 5</arg>
                    <arg n="R">exon skipping</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>this suppression that can disrupt consensus signal 5 has been identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">this suppression</arg>
                    <arg n="1">consensus signal 5</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>tumour binding system 2 maneuver broke the tumour vessels and disrupted to the similar effects on peripheral nerves.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                    <arg n="R">similar effects on peripheral nerves</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>tumour binding system 2 maneuver have perturbed tumour vessels and disrupted in similar effects on peripheral nerves.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                    <arg n="R">similar effects on peripheral nerves</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>tumour binding system 2 maneuver that has disrupted tumour vessels was identified in affected siblings with classical abetalipoproteinemia.</text>
                    <arg n="0">tumour binding system 2 maneuver</arg>
                    <arg n="1">tumour vessels</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
